Начало › Рак на гърдата › Охайо › Cleveland
Клинични проучвания за Рак на гърдата в Cleveland, OH
35 проучвания за Рак на гърдата търсят участници в обекти в и около Cleveland (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- Louis Stokes Cleveland VA Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Набиране на участнициФаза 2
- Cleveland Clinic - Oncology Department, Cleveland
Study of AVZO-021 in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Avenzo Therapeutics Recruiting Site, Cleveland
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Набиране на участнициФаза 3
- Research Site, Cleveland
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Cleveland Clinic, Cleveland
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Набиране на участници
- Cleveland Clinic, Cleveland
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Набиране на участнициФаза 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · на 12 мили
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Набиране на участнициФаза 1/2
- UH Cleveland Medical Center, Cleveland
Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
Набиране на участници
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Набиране на участнициФаза 3
- MetroHealth, Cleveland
- Cleveland Clinic, Cleveland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набиране на участнициФаза 1
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Набиране на участнициФаза 1
- Cleveland Clinic Foundation, Cleveland
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Набиране на участнициФаза 3
- Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Hillcrest Hospital, Mayfield Heights · на 12 мили
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Набиране на участнициФаза 3
- Cleveland Clinic, Cleveland
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Набиране на участнициФаза 3
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- South Pointe Hospital, Warrensville Heights · на 9 мили
- и още 1
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- Cleveland Clinic, Cleveland
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Набиране на участнициФаза 1
- Cleveland Clinic Taussig Cancer Institute, Cleveland
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Набиране на участнициФаза 2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Набиране на участнициФаза 2
- Case Western Reserve University, Cleveland
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Набиране на участници
- Case Western Reserve University/University Hospitals Cleveland, Cleveland
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Набиране на участнициФаза 1
- UHCMC Seidman Cancer Center, Cleveland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- UH Cleveland Medical Center, Cleveland
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Набиране на участнициФаза 3
- University Hospitals Seidman Cancer Center, Cleveland
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Набиране на участнициФаза 2
- Cleveland Clinic, Cleveland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Набиране на участнициФаза 2
- Cleveland Clinic, Cleveland
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Набиране на участнициФаза 3
- Case Western Reserve University, Cleveland
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- и още 3
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Набиране на участнициФаза 1/2
- Cleveland Clinic, Cleveland
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Набиране на участнициНаблюдателно проучване
- University Hospitals Seidman Cancer Center, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Cleveland Clinic, Cleveland
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Набиране на участнициНаблюдателно проучване
- Cleveland Clinic Main Campus, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Mayfield Heights · на 12 мили
The Cancer of the Pancreas Screening-5 CAPS5)Study
Набиране на участнициФаза 3
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Набиране на участнициФаза 3
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- и още 3
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Exelixis Clinical Site #7, Cleveland
Проучвания за Рак на гърдата в други градове
- New York City, NY136 проучвания
- Houston, TX126 проучвания
- Boston, MA112 проучвания
- Nashville, TN81 проучвания
- Los Angeles, CA73 проучвания
- Edison, NJ68 проучвания
- St. Louis, MO64 проучвания
- Queens, NY64 проучвания
- Durham, NC64 проучвания
- Chicago, IL59 проучвания
- Philadelphia, PA56 проучвания
- Dallas, TX55 проучвания
Други проучвания в Cleveland
- Рак на белия дроб с недребноклетъчен тип43 проучвания
- Рак (всички видове)36 проучвания
- Рак на простатата34 проучвания
- Сърдечна недостатъчност33 проучвания
- Рак на яйчниците30 проучвания
- Метастатичен рак30 проучвания
- Рак на белия дроб26 проучвания
- Колоректален рак24 проучвания
- Сърдечно-съдово заболяване22 проучвания
- Ендометриален рак20 проучвания
- Остра миелоидна левкемия20 проучвания
- Болест на Крон19 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.